Rapid HIV Treatment Initiation, Access and Engagement in Care
Status:
Completed
Trial end date:
2020-09-13
Target enrollment:
Participant gender:
Summary
The investigators propose to evaluate Rapid HIV Treatment Initiation in Baltimore in newly
and previously diagnosed HIV-positive patients not in care through identification of
barriers, facilitators and acceptability of Rapid HIV Treatment Initiation among newly and
previously diagnosed HIV-positive patients not in care identified at the Johns Hopkins East
Baltimore campus and at the Baltimore City Health Department sexually transmitted disease
clinics. Using this data, a protocol for Rapid HIV Treatment Initiation among newly and
previously diagnosed HIV-positive patients not in care identified at the Johns Hopkins East
Baltimore campus and the Baltimore City Health Department sexually transmitted disease
clinics will be developed and pilot tested. This pilot data will be used to design a
multi-site study evaluating the effectiveness of Rapid HIV Treatment Initiation versus
facilitated linkage to care. A model for Rapid HIV Treatment Initiation in Baltimore could be
generalized to cities where the HIV epidemic has a similar demographic and risk profile such
as Washington DC, Atlanta, and New York City.
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)